All 255 IBB (ISHARES BIOTECHNOLOGY ETF) Holdings
There are 255 IBB holdings. Top 10 companies weight: 45.35%.
Total Market Cap: $1.46T
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (255 stocks) | +21.29% | 22.10 | 16.14 | 0.50 | +43.28% | +8.52% | 0.87 | ||||||||||
101 | ANAB | Anaptysbio Inc | 0.14% | $51.26 | $1.67B | Biotechnology | Healthcare | -4.15% | N/A | N/A | N/A | N/A | N/A | 79 | +64.75% | $84 | +26.40% | 0.81 |
102 | QURE | Uniqure Nv | 0.13% | $26.76 | $1.59B | Biotechnology | Healthcare | +2.11% | N/A | 27.93 | N/A | N/A | N/A | 69 | +46.38% | $39 | -5.16% | 1.33 |
103 | IOVA | Iovance Biotherapeutics Inc | 0.13% | $4.10 | $1.91B | Biotechnology | Healthcare | -12.60% | N/A | N/A | N/A | N/A | N/A | 75 | +114.63% | $8.80 | -25.12% | 1.66 |
104 | RXRX | Recursion Pharmaceuticals Inc Class A | 0.13% | $3.61 | $1.68B | Biotechnology | Healthcare | -10.03% | N/A | N/A | N/A | N/A | N/A | 65 | +83.93% | $6.64 | -33.81% | 2.60 |
105 | NTLA | Intellia Therapeutics Inc | 0.13% | $13.13 | $1.62B | Biotechnology | Healthcare | +8.10% | N/A | N/A | N/A | N/A | N/A | 62 | +102.82% | $27 | -28.75% | 1.70 |
106 | NVAX | Novavax Inc | 0.13% | $10.21 | $1.82B | Biotechnology | Healthcare | -42.97% | N/A | 2.59 | 1.32 | N/A | N/A | 50 | +38.20% | $14 | -43.27% | 1.50 |
107 | STOK | Stoke Therapeutics Inc | 0.12% | $28.68 | $1.96B | Biotechnology | Healthcare | +11.95% | N/A | 204.08 | N/A | N/A | N/A | 77 | +57.25% | $45 | -5.78% | 1.09 |
108 | ATAI | Ataibeckley Inc | 0.12% | $4.81 | $1.58B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 78 | +191.06% | $14 | 0.00% | 1.42 |
109 | AMLX | Amylyx Pharmaceuticals Inc | 0.12% | $13.29 | $1.56B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | N/A | 2.77 | N/A | N/A | N/A | 72 | +76.07% | $23 | 0.00% | 1.15 |
110 | TSHA | N/A | 0.11% | $5.69 | $1.65B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 80 | +114.94% | $12 | -23.73% | 1.40 |
111 | TRVI | Trevi Therapeutics Inc | 0.11% | $13.50 | $1.86B | Biotechnology | Healthcare | -27.09% | N/A | N/A | N/A | N/A | N/A | 79 | +77.04% | $24 | +43.35% | 0.64 |
112 | NUVB | N/A | 0.11% | $4.90 | $1.64B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +151.63% | $12 | -18.26% | 1.49 |
113 | n/a | Blackrock Cash Funds Treasury Sl Agency | 0.11% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
114 | BHVN | Biohaven Ltd | 0.11% | $10.12 | $1.70B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 73 | +114.53% | $22 | 0.00% | 1.53 |
115 | ABCL | Abcellera Biologics Inc Ordinary Shares | 0.11% | $6.13 | $1.65B | Biotechnology | Healthcare | N/A | N/A | 27.55 | N/A | N/A | N/A | 75 | +70.15% | $10 | -24.85% | 1.61 |
116 | CMPS | Compass Pathways Plc Adr | 0.11% | $13.33 | $1.60B | Medical Care Facilities | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 78 | +66.54% | $22 | -16.86% | 1.39 |
117 | FTRE | Fortrea Holdings Inc | 0.11% | $15.36 | $1.27B | Biotechnology | Healthcare | N/A | N/A | 9.16 | 0.34 | N/A | N/A | 56 | +5.53% | $16 | 0.00% | 1.90 |
118 | TYRA | Tyra Biosciences Inc | 0.11% | $28.66 | $1.97B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 76 | +78.47% | $51 | 0.00% | 1.05 |
119 | SION | Sionna Therapeutics Inc | 0.10% | $36.48 | $1.96B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 70 | +41.45% | $52 | 0.00% | 0.93 |
120 | GRFS | Grifols Sa Adr | 0.10% | $7.63 | $5.48B | Drug Manufacturers - General | Healthcare | -10.20% | 11.29 | 8.73 | 0.08 | N/A | N/A | 62 | +42.46% | $11 | -14.28% | 0.89 |
121 | RAPP | Rapport Therapeutics Inc | 0.10% | $34.90 | $1.89B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +63.61% | $57 | 0.00% | 1.35 |
122 | IMCR | Immunocore Holdings Plc Adr | 0.10% | $29.56 | $1.45B | Biotechnology | Healthcare | N/A | N/A | 196.08 | N/A | N/A | N/A | 70 | +114.78% | $63 | -6.08% | 0.72 |
123 | INBX | Inhibrx Biosciences Inc | 0.10% | $93.63 | $1.50B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 62 | +196.38% | $278 | 0.00% | 1.39 |
124 | URGN | Urogen Pharma Ltd | 0.10% | $26.54 | $1.43B | Biotechnology | Healthcare | -11.74% | N/A | N/A | N/A | N/A | N/A | 75 | +38.96% | $37 | +7.68% | 1.18 |
125 | CDNA | Caredx Inc | 0.09% | $22.07 | $1.14B | Diagnostics & Research | Healthcare | -10.97% | N/A | 94.34 | N/A | N/A | N/A | 60 | +16.90% | $26 | -22.71% | 1.31 |
126 | GHRS | Gh Research Plc | 0.09% | $24.87 | $1.39B | Biotechnology | Healthcare | +89.13% | N/A | N/A | N/A | N/A | N/A | 83 | +58.83% | $40 | 0.00% | 0.97 |
127 | MESO | Mesoblast Ltd Adr | 0.09% | $14.52 | $2.02B | Biotechnology | Healthcare | -10.27% | N/A | 454.55 | N/A | N/A | N/A | 91 | +141.05% | $35 | +0.48% | 1.40 |
128 | WVE | Wave Life Sciences Ltd | 0.09% | $5.69 | $1.22B | Biotechnology | Healthcare | -19.81% | N/A | N/A | N/A | N/A | N/A | 78 | +285.59% | $22 | -3.81% | 1.46 |
129 | VIR | Vir Biotechnology Inc | 0.09% | $8.74 | $1.47B | Biotechnology | Healthcare | -0.01% | N/A | 4.27 | N/A | N/A | N/A | 82 | +135.24% | $21 | -28.26% | 1.58 |
130 | KALV | Kalvista Pharmaceuticals Inc | 0.09% | $26.94 | $1.37B | Biotechnology | Healthcare | +11.29% | N/A | 25.45 | N/A | N/A | N/A | 60 | +6.16% | $29 | +0.41% | 0.87 |
131 | KURA | Kura Oncology Inc | 0.09% | $8.97 | $909M | Biotechnology | Healthcare | +15.40% | N/A | N/A | N/A | N/A | N/A | 76 | +247.49% | $31 | -15.97% | 1.07 |
132 | MNKD | Mannkind Corp | 0.09% | $3.43 | $1.10B | Biotechnology | Healthcare | -21.18% | N/A | 37.31 | 4.39 | N/A | N/A | 71 | +121.28% | $7.59 | -2.03% | 0.72 |
133 | LKFT | Lakefront Biotherapeutics Nv Adr | 0.09% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
134 | OLMA | N/A | 0.09% | $10.69 | $1.13B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 76 | +291.21% | $42 | -17.30% | 0.70 |
135 | MBX | Mbx Biosciences Inc | 0.08% | $30.70 | $1.52B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +125.05% | $69 | 0.00% | 1.46 |
136 | CRVS | Corvus Pharmaceuticals Inc | 0.08% | $11.69 | $1.09B | Biotechnology | Healthcare | +53.96% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | +34.16% | N/A |
137 | GLUE | Monte Rosa Therapeutics Inc | 0.08% | $17.74 | $1.62B | Biotechnology | Healthcare | N/A | N/A | 10.02 | N/A | N/A | N/A | 81 | +82.24% | $32 | 0.00% | 1.35 |
138 | STVN | Stevanato Group Spa | 0.08% | $18.79 | $4.93B | Medical Instruments & Supplies | Healthcare | +7.16% | 29.88 | 19.46 | 1.31 | N/A | N/A | 75 | +32.14% | $25 | 0.00% | 0.89 |
139 | MAZE | Maze Therapeutics Inc | 0.08% | $24.29 | $1.30B | Biotechnology | Healthcare | N/A | N/A | 8.53 | N/A | N/A | N/A | 77 | +157.51% | $63 | 0.00% | 0.89 |
140 | XNCR | Xencor Inc | 0.07% | $11.21 | $868M | Biotechnology | Healthcare | +10.21% | N/A | 68.03 | N/A | N/A | N/A | 76 | +154.24% | $29 | -21.07% | 1.50 |
141 | SEPN | Septerna Inc | 0.07% | $29.94 | $1.34B | Biotechnology | Healthcare | N/A | N/A | 107.53 | N/A | N/A | N/A | 77 | +47.80% | $44 | 0.00% | 1.32 |
142 | PHVS | Pharvaris Nv Ordinary Shares | 0.07% | $28.98 | $1.92B | Biotechnology | Healthcare | +9.20% | N/A | N/A | N/A | N/A | N/A | 78 | +60.80% | $47 | +7.21% | 0.71 |
143 | TBPH | Theravance Biopharma Inc | 0.07% | $15.58 | $838M | Biotechnology | Healthcare | N/A | 11.78 | 7.45 | N/A | N/A | N/A | 62 | +11.68% | $17 | -1.45% | 0.58 |
144 | AVBP | Arrivent Biopharma Inc | 0.07% | $29.92 | $1.24B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +40.71% | $42 | 0.00% | 0.94 |
145 | GERN | Geron Corp | 0.07% | $1.17 | $843M | Biotechnology | Healthcare | -18.28% | N/A | N/A | N/A | N/A | N/A | 66 | +190.60% | $3.40 | -3.53% | 1.20 |
146 | ANNX | Annexon Inc Ordinary Shares | 0.07% | $5.26 | $1.05B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 80 | +149.43% | $13 | -24.63% | 1.29 |
147 | BCAX | Bicara Therapeutics Inc | 0.07% | $19.64 | $1.41B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +60.18% | $31 | 0.00% | 1.44 |
148 | JANX | Janux Therapeutics Inc Ordinary Shares | 0.07% | $13.78 | $879M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 70 | +194.34% | $41 | 0.00% | 1.23 |
149 | ABSI | Absci Corp | 0.06% | $6.35 | $789M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +38.43% | $8.79 | 0.00% | 2.25 |
150 | ABUS | Arbutus Biopharma Corp | 0.06% | $4.26 | $914M | Biotechnology | Healthcare | N/A | 5.69 | 10.25 | N/A | N/A | N/A | 83 | +20.66% | $5.14 | +7.63% | 0.91 |
IBB (ISHARES BIOTECHNOLOGY ETF) Sector Allocation
HEALTHCARE
94.10%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%MATERIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%